Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising ...
To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...
New 'AI GYM for Science' dramatically boosts the biological and chemical intelligence of any causal or frontier LLMUp to 10x performance gains on key drug discovery benchmarks compared to LLMs that ...
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss how involving procurement ...
New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...
In drug development, success often hinges on a deceptively simple question: how will the body respond? For Dr. Kidochukwu ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...
Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...
Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results